A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants

Conditions: Healthy Participants Interventions: Drug: DC-806; Drug: Midazolam; Drug: Repaglinide; Drug: Digoxin; Drug: Rosuvastatin Sponsors: DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials